Free Trial

Teleflex (TFX) Stock Forecast & Price Target

Teleflex logo
$180.14 +2.88 (+1.62%)
(As of 05:41 PM ET)

Teleflex - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
4

Based on 7 Wall Street analysts who have issued ratings for Teleflex in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 3 have given a hold rating, and 4 have given a buy rating for TFX.

Consensus Price Target

$252.50
40.17% Upside
According to the 7 analysts' twelve-month price targets for Teleflex, the average price target is $252.50. The highest price target for TFX is $290.00, while the lowest price target for TFX is $200.00. The average price target represents a forecasted upside of 40.17% from the current price of $180.14.
Get the Latest News and Ratings for TFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Teleflex and its competitors.

Sign Up

TFX Analyst Ratings Over Time

TypeCurrent Forecast
12/27/23 to 12/26/24
1 Month Ago
11/27/23 to 11/26/24
3 Months Ago
9/28/23 to 9/27/24
1 Year Ago
12/27/22 to 12/27/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$252.50$259.25$265.57$264.90
Forecasted Upside40.17% Upside35.72% Upside7.59% Upside5.74% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

TFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Teleflex Stock vs. The Competition

TypeTeleflexMedical CompaniesS&P 500
Consensus Rating Score
2.57
2.81
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside40.50% Upside25,657.91% Upside13.40% Upside
News Sentiment Rating
Positive News

See Recent TFX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/18/2024Truist Financial
2 of 5 stars
 Lower TargetHold ➝ Hold$227.00 ➝ $200.00+13.07%
12/16/2024Needham & Company LLC
2 of 5 stars
 Reiterated RatingHold ➝ Hold
11/1/2024Royal Bank of Canada
4 of 5 stars
 Lower TargetOutperform ➝ Outperform$275.00 ➝ $245.00+17.39%
11/1/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$275.00 ➝ $250.00+19.79%
8/2/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$275.00 ➝ $290.00+21.26%
7/1/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. O'brien
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$205.00 ➝ $245.00+16.48%
Mysterious drone activity triggers massive 1,366% surge (Ad)

If mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.

👉 Click here now to see how this signal works.
2/23/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Outperform ➝ Market Outperform$285.00+18.29%
12/20/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$227.00 ➝ $271.00+6.76%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$261.00+14.64%
5/30/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$293.00+24.97%
4/26/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Peer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:25 PM ET.


TFX Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Teleflex is $252.50, with a high forecast of $290.00 and a low forecast of $200.00.

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TFX shares.

According to analysts, Teleflex's stock has a predicted upside of 40.17% based on their 12-month stock forecasts.

Teleflex has been rated by research analysts at Mizuho, Needham & Company LLC, Royal Bank of Canada, and Truist Financial in the past 90 days.

Analysts like Teleflex less than other "medical" companies. The consensus rating score for Teleflex is 2.57 while the average consensus rating score for "medical" companies is 2.81. Learn more on how TFX compares to other companies.


This page (NYSE:TFX) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners